1. Home
  2. QTWO vs CYTK Comparison

QTWO vs CYTK Comparison

Compare QTWO & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTWO
  • CYTK
  • Stock Information
  • Founded
  • QTWO 2004
  • CYTK 1997
  • Country
  • QTWO United States
  • CYTK United States
  • Employees
  • QTWO N/A
  • CYTK N/A
  • Industry
  • QTWO Computer Software: Prepackaged Software
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • QTWO Technology
  • CYTK Health Care
  • Exchange
  • QTWO Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • QTWO 4.7B
  • CYTK 4.6B
  • IPO Year
  • QTWO 2014
  • CYTK 2004
  • Fundamental
  • Price
  • QTWO $62.21
  • CYTK $60.10
  • Analyst Decision
  • QTWO Buy
  • CYTK Strong Buy
  • Analyst Count
  • QTWO 15
  • CYTK 15
  • Target Price
  • QTWO $104.14
  • CYTK $76.73
  • AVG Volume (30 Days)
  • QTWO 1.0M
  • CYTK 1.8M
  • Earning Date
  • QTWO 11-05-2025
  • CYTK 11-05-2025
  • Dividend Yield
  • QTWO N/A
  • CYTK N/A
  • EPS Growth
  • QTWO N/A
  • CYTK N/A
  • EPS
  • QTWO 0.07
  • CYTK N/A
  • Revenue
  • QTWO $742,949,000.00
  • CYTK $85,738,000.00
  • Revenue This Year
  • QTWO $15.14
  • CYTK $363.61
  • Revenue Next Year
  • QTWO $10.56
  • CYTK $64.08
  • P/E Ratio
  • QTWO $796.38
  • CYTK N/A
  • Revenue Growth
  • QTWO 13.34
  • CYTK 2635.74
  • 52 Week Low
  • QTWO $58.57
  • CYTK $29.31
  • 52 Week High
  • QTWO $112.82
  • CYTK $63.86
  • Technical
  • Relative Strength Index (RSI)
  • QTWO 37.25
  • CYTK 60.22
  • Support Level
  • QTWO $60.84
  • CYTK $54.30
  • Resistance Level
  • QTWO $62.80
  • CYTK $60.78
  • Average True Range (ATR)
  • QTWO 1.58
  • CYTK 2.42
  • MACD
  • QTWO 0.60
  • CYTK -0.52
  • Stochastic Oscillator
  • QTWO 63.44
  • CYTK 60.67

About QTWO Q2 Holdings Inc.

Q2 Holdings Inc. is a provider of cloud-based virtual banking solutions for regional financial institutions to deliver mobile banking services to retail and commercial end-users who wish to bank anywhere and anytime. Its solutions operate on an integrated tablet-first platform which provides financial institutions a comprehensive view of account holder activity and meets the regulatory and security requirements applicable to the industry. The firm generates revenue from subscription-based arrangements for software offerings. A large majority of the firm's revenue is generated in the United States.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: